Document Detail


Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.
MedLine Citation:
PMID:  23450128     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Phosphatidylinositol-3-kinase (PI3K) activation involves the epidermal growth factor receptor (EGFR) and plays an important role in cell survival signaling in pancreaticobiliary cancer. EGFR gene mutations have been correlated with clinical response to EGFR inhibitors in patients with advanced non-small cell lung cancer. This study examined the prevalence of PIK3CA and EGFR mutations in pancreaticobiliary cancer where erlotinib, an EGFR inhibitor, is approved for therapy.
METHODS: Thirty patients who underwent pancreatectomy for pancreaticobiliary carcinoma were identified. Genomic DNA was extracted from formalin fixed paraffin embedded tumor and adjacent normal tissue, and exons 9 and 20 (for the PIK3CA gene) and exons 18-21 (for the EGFR gene) were amplified by PCR and sequenced. Literature review on EGFR and/or PIK3CA mutations in pancreaticobiliary adenocarcinomas was conducted.
RESULTS: No mutations in either PIK3CA or EGFR genes were identified. The study identified one synonymous single nucleotide polymorphism (SNP) (rs1050171) in the coding region of EGFR. A previously unreported change, suspected to be a SNP, was observed in intron 18 of EGFR (IVS18+15, C>T). Review of the literature showed EGFR mutation rate of 2% and 10.5% in pancreatic and biliary tract carcinomas, respectively. PIK3CA mutations were found in 3.6% and 11.7% of pancreatic and biliary tract carcinomas, respectively.
CONCLUSIONS: A low prevalence of EGFR or PIK3CA mutations exists in pancreatic cancer (<5%), indicating that mutation screening may not be as useful in determining prognosis or response to targeted inhibition.
Authors:
Guy A Weiss; Michael R Rossi; Nikhil I Khushalani; Ken Lo; John F Gibbs; Anubha Bharthuar; John K Cowell; Renuka Iyer
Related Documents :
23723338 - Association between genotype and phenotype in uromodulin-associated kidney disease.
25069408 - Multiplex pyrosequencing method to determine cyp2c9*3, vkorc1*2, and cyp4f2*3 polymorph...
23039078 - Incidence of beta thalassemia carrier on 1495 couples in preconceptional period.
24759998 - Linkage disequilibrium and genome-wide association mapping in tetraploid wheat (triticu...
9241658 - Frequent occurrence of cyp2d6 gene duplication in saudi arabians.
23826218 - Wild-type mitochondrial dna copy number in urinary cells as a useful marker for diagnos...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of gastrointestinal oncology     Volume:  4     ISSN:  2078-6891     ISO Abbreviation:  J Gastrointest Oncol     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-01     Completed Date:  2013-03-04     Revised Date:  2013-04-18    
Medline Journal Info:
Nlm Unique ID:  101557751     Medline TA:  J Gastrointest Oncol     Country:  China    
Other Details:
Languages:  eng     Pagination:  20-9     Citation Subset:  -    
Affiliation:
Department of Medicine, University at Buffalo, Buffalo, New York, USA;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis of a cobalt(iv) ketimide with a squashed tetrahedral geometry.
Next Document:  Copper-catalyzed aldol-type addition of ketones to aromatic nitriles: a simple approach to enaminone...